Found: 41
Select item for more details and to access through your institution.
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 1, p. 13, doi. 10.1007/s11095-023-03627-5
- By:
- Publication type:
- Article
Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins.
- Published in:
- AAPS Journal, 2023, v. 25, n. 4, p. 1, doi. 10.1208/s12248-023-00819-0
- By:
- Publication type:
- Article
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors.
- Published in:
- AAPS Journal, 2020, v. 22, n. 2, p. 1, doi. 10.1208/s12248-020-0433-8
- By:
- Publication type:
- Article
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
- Published in:
- AAPS Journal, 2018, v. 20, n. 6, p. 1, doi. 10.1208/s12248-018-0257-y
- By:
- Publication type:
- Article
Evaluating and Reporting the Immunogenicity Impacts for Biological Products-a Clinical Pharmacology Perspective.
- Published in:
- AAPS Journal, 2016, v. 18, n. 2, p. 395, doi. 10.1208/s12248-015-9857-y
- By:
- Publication type:
- Article
Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications.
- Published in:
- AAPS Journal, 2014, v. 16, n. 5, p. 938, doi. 10.1208/s12248-014-9637-0
- By:
- Publication type:
- Article
Bioanalytical Method Validation: Concepts, Expectations and Challenges in Small Molecule and Macromolecule—A Report of PITTCON 2013 Symposium.
- Published in:
- AAPS Journal, 2014, v. 16, n. 3, p. 586, doi. 10.1208/s12248-014-9597-4
- By:
- Publication type:
- Article
Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys.
- Published in:
- AAPS Journal, 2010, v. 12, n. 4, p. 646, doi. 10.1208/s12248-010-9222-0
- By:
- Publication type:
- Article
Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects.
- Published in:
- AAPS Journal, 2010, v. 12, n. 4, p. 729, doi. 10.1208/s12248-010-9234-9
- By:
- Publication type:
- Article
Romiplostim dose-response in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 6, p. 1445, doi. 10.1111/bcp.12041
- By:
- Publication type:
- Article
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report.
- Published in:
- AAPS Open, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41120-021-00050-1
- By:
- Publication type:
- Article
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 440, doi. 10.1002/cpt.3178
- By:
- Publication type:
- Article
Pharmacokinetics‐Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 404, doi. 10.1002/cpt.3145
- By:
- Publication type:
- Article
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 412, doi. 10.1002/cpt.3133
- By:
- Publication type:
- Article
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1030, doi. 10.1002/cpt.2795
- By:
- Publication type:
- Article
Leveraging Clinical Pharmacology Data to Assess Biosimilarity and Interchangeability of Insulin Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 794, doi. 10.1002/cpt.2731
- By:
- Publication type:
- Article
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 2, p. 339, doi. 10.1002/cpt.2784
- By:
- Publication type:
- Article
Advancing Innovations in Biosimilars.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 11, doi. 10.1002/cpt.2782
- By:
- Publication type:
- Article
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 37, doi. 10.1002/cpt.2765
- By:
- Publication type:
- Article
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ‐1a Biologics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 98, doi. 10.1002/cpt.2778
- By:
- Publication type:
- Article
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with PCSK9 Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 71, doi. 10.1002/cpt.2769
- By:
- Publication type:
- Article
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 55, doi. 10.1002/cpt.2761
- By:
- Publication type:
- Article
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (II) A Randomized Trial with IL‐5 Antagonists.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 80, doi. 10.1002/cpt.2760
- By:
- Publication type:
- Article
Model‐Based Approach to Selecting Pegfilgrastim Dose for Pharmacokinetic and Pharmacodynamic Similarity Studies in Biosimilar Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 62, doi. 10.1002/cpt.2722
- By:
- Publication type:
- Article
Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and Commitments.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 697, doi. 10.1002/cpt.2038
- By:
- Publication type:
- Article
Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 40, doi. 10.1002/cpt.1653
- By:
- Publication type:
- Article
Effect of Body Weight on Risk‐Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 78, doi. 10.1002/cpt.1478
- By:
- Publication type:
- Article
Considerations for Biologic Product Drug–Drug Interactions: A Regulatory Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 6, p. 1332, doi. 10.1002/cpt.1366
- By:
- Publication type:
- Article
Population pharmacokinetic-pharmacodynamic modeling of omecamtiv mecarbil, a cardiac myosin activator, in healthy volunteers and patients with stable heart failure.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1236, doi. 10.1002/jcph.538
- By:
- Publication type:
- Article
Digoxin Disposition in Elderly Humans with Hypochlorhydria.
- Published in:
- 1994
- By:
- Publication type:
- Other
Evaluation of Truncated AUC as an Alternative Measure to Assess Pharmacokinetic Comparability in Bridging Biologic–Device Using Prefilled Syringes and Autoinjectors.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1417, doi. 10.1002/jcph.2322
- By:
- Publication type:
- Article
Exploring the Knowledge Gaps in Infant Drug Exposure From Human Milk: A Clinical Pharmacology Perspective.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 3, p. 273, doi. 10.1002/jcph.2177
- By:
- Publication type:
- Article
Monoclonal Antibodies and Fc‐Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1130, doi. 10.1002/jcph.1406
- By:
- Publication type:
- Article
On placental and lactational transfer of IgG‐based therapeutic proteins – Current understanding and knowledge gaps from a clinical pharmacology perspective.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 10, p. 1, doi. 10.1111/cts.70049
- By:
- Publication type:
- Article
Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2438, doi. 10.1111/cts.13652
- By:
- Publication type:
- Article
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2096, doi. 10.1111/cts.13345
- By:
- Publication type:
- Article
Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 2, p. 219, doi. 10.1111/cts.12717
- By:
- Publication type:
- Article
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 5, p. 992, doi. 10.1002/cncr.25545
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim in Animals.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 3, p. 655, doi. 10.1007/s11095-012-0894-2
- By:
- Publication type:
- Article
A Survey of Applications of Biological Products for Drug Interference of Immunogenicity Assays.
- Published in:
- Pharmaceutical Research, 2012, v. 29, n. 12, p. 3384, doi. 10.1007/s11095-012-0833-2
- By:
- Publication type:
- Article
Investigation of the Pharmacokinetics of Romiplostim in Rodents with a Focus on the Clearance Mechanism.
- Published in:
- Pharmaceutical Research, 2011, v. 28, n. 8, p. 1931, doi. 10.1007/s11095-011-0420-y
- By:
- Publication type:
- Article